Huvepharma and Checkerspot entered a commercial-purpose partnership contract

Image Credit: Vegconomist

Announcement 

Checkerspot, a certified B corporation and a leading biotechnology company that works on renewable oils and fats via the fermentation of microalgae, and Huvepharma, a known leading fermentation and biopharmaceutical company, have entered a commercial-purpose partnership for an excellent human milk fat analog. The partnership intends to create and commercialize high sn-2 palmitate algal oil at the industrial level. This is an accurate alternative to the latest available palm-derived nutritional oil in the market. The partnership will be the competition in the commercial market. The high sn-2 palmitate algal oil as an exploratory alternative will scale in the commercial product sector.

Proven alternative evidence of high sn-2 palmitate algal oil

The palm-derived nutritional oil matches the crucial triglyceride structures that are visible in human milk fat. It becomes appropriate for enhanced nutrition applications and infant formula. The high sn-2 palmitate oil is essential for infant nutrition, contributing best to the digestive system and nutrient absorption. Its origin is from the fermentation of simple sugars by microalgae; the high sn-2 palmitate algal oil discards the requirement for bypasses enzymatic modification and palm-related precursors. This provides a sustainable and hygienic process in comparison to the recent commercialized ingredients.

There’s no mere processing, adulteration, or environmental contaminants. Its consistency in composition, characteristic of an accurate fermentation process, makes it viable. The oil promises a quality stage of safety and consistency. With this progress, Huvepharma and checkerspot will place algal oil at a scalable level and introduce it as a sustainable solution to supply and environmental hurdles. Alongside, unlocking new opportunities for infant formula companies to uplift their formations with the initiative to level up their performance.

Views and statements from company leaders

The president and CEO of Huvépharma, Kiril Domuschiev, said, “Checkerspot’s brilliant high sn-2 palmitate algal oil is way beneficial for infant nutrition, marking as environmental impact and nutritional quality both. Huvepharma’s ocean level expertise in fermentation at the global market and scale presence best fits the collaboration to serve this competitive and innovative, reliable to the infant nutrition company.”

The CEO of Checkerspot, John Krzywicki, said, “Collaborating with Huvepharma enables us to introduce high sn-2 palmitate algal oil to the industrial scale and confirm its availability to infant formula brands globally. This is a major milestone in proving with explanation the quality performance of oils and fats that are sourced and produced.”